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The progression of androgenetic alopecia is closely related to 
androgen-inducible transforming growth factor (TGF)-β1 secre-
tion by hair follicle dermal papilla cells (DPCs) in bald scalp. 
Physiological levels of androgen exposure were reported to 
increase reactive oxygen species (ROS) generation. In this 
study, rat vibrissae dermal papilla cells (DP-6) transfected with 
androgen receptor showed increased ROS production following 
androgen treatment. We confirmed that TGF-β1 secretion is 
increased by androgen treatment in DP-6, whereas androgen- 
inducible TGF-β1 was significantly suppressed by the ROS- 
scavenger, N-acetyl cysteine. Therefore, we suggest that induc-
tion of TGF-β1 by androgen is mediated by ROS in hair follicle 
DPCs. [BMB Reports 2013; 46(9): 460-464]
INTRODUCTION
Androgenetic alopecia (AGA) is characterized by androgen- 
dependent progressive thinning and balding of scalp hair that 
follows a defined pattern in genetically predisposed subjects 
(1, 2). Moreover, androgen affects hair growth (3), and the 
balding scalps exhibit higher levels of 5-alpha reductase and 
elevated androgen receptor (AR) expression in dermal papilla 
cells (DPCs) of hair follicles compared to normal hair-bearing 
scalps (4-6). In human hair follicles, it is generally accepted 
that androgen acts via the dermal papilla. Androgen regulates 
factors derived from DPCs, which are believed to influence the 
growth of hair follicle components (7-10). The role of an-
drogens in hair growth regulation was previously reported in 
an in vitro co-culture system of human DPCs from AGA pa-
tients and keratinocytes (KC) (11). The study revealed that an-
drogen-inducible transforming growth factor (TGF)-β1 secre-
tion from balding DPCs inhibits epithelial cell growth. 
　Reactive oxygen species (ROS) are known to be profoundly 
increased in aged cells. In addition, high ROS levels, induced 
by oxidative stress, promote damage of cellular DNA, proteins, 
and lipids. Such damage can lead to cell-cycle arrest, cellular 
senescence, and even cellular death (12). Interestingly, the 
ROS hydrogen peroxide has been reported to induce TGF-β in 
epithelial cells (13). In addition, it was revealed that physio-
logical levels of androgen exposure resulted in increased lev-
els of ROS generation in androgen-sensitive human prostate 
cancer cells (14). 
　We postulated that androgen may play a significant role in 
regulating the ROS balance in DPCs, which, in turn, would in-
fluence the secretion of TGF-β1 and inhibit the proliferation of 
hair matrix epithelial cells. The aim of this study was to clarify 
the role of ROS in androgen-inducible TGF-β1 expression in 
DPCs. We investigated the effects of androgen on ROS pro-
duction and on TGF-β1 secretion in DPCs, and then examined 
whether an antioxidant treatment could reverse the effects of 
ROS on androgen-induced TGF-β1 secretion by these cells.
RESULTS 
Establishment of AR over-expressing rat DPCs (DP6-AR cells) 
We transfected DP6 cells with rat AR cloning retroviral vector 
(p-Babe-rat AR-HA-puro). Western blot analysis revealed that 
AR was expressed on the DP6-AR cells, but not the control 
cells transfected with the puro vector only (data not shown). 
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Fig. 1. Intracellular ROS production by DP6-AR cells stimulated 
with R1881, but then reduced following pre-treatment with NAC. 
(A) The amounts of ROS induced by R1881 were determined by 
FACS in DP6-AR cells (lane B, C). Pre-treatment with NAC at 
doses ranging from 0.5 mM to 2.5 mM for 2 h modulated ROS 
expression in response to 10-7 M R1881 in cultured DP6-AR cells 
(lane D, E, F). All results are the mean values of experiments 
performed in triplicate. Error bars indicate standard errors. ANOVA 
was performed at first and independent t-test was done for post 
hoc. *P ＜ 0.05 versus control cells transfected with puro (mock) 
vector only (lane A). †P ＜ 0.05 versus treatment with 10-7 M 
R1881 (lane C). ROS, reactive oxygen species; NAC, N-acetyl cys-
teine, a ROS scavenger; R1881, methyltrienolone, a synthetic 
androgen. (B) (a) Vehicle treatment. (negative control) (b) Treatment 
with 100 μM H2O2 (positive control) (c) Exposure of DP6-AR 
cells to 10-7 M R1881. (d) R1881 exposure after pre-treatment with 
NAC for 2 h.
Fig. 2. Analysis of active TGF-β1 levels by ELISA after treatment with 
H2O2. The DP6-AR (5.0 × 105 cells/dish) cells were treated with 
H2O2 at 10, 50, or 100 μM for 24 h and the conditioned media 
were harvested. Concentrations of the active form of TGF-β1 in 
the conditioned media were measured using a specific ELISA. All 
results are the mean values of experiments performed in triplicate. 
Error bars indicate standard errors. ANOVA was performed at first 
and independent t-test was done for post hoc. *P ＜ 0.05 versus 
control. CNT, control; TGF-β1, transforming growth factor-β1.
Androgen markedly increased ROS generation by the DP6- 
AR cells 
DP6-AR cells were incubated with 10-9 and 10-7 M R1881, and 
ROS generation was quantitatively measured by flow cytometry. 
ROS was generated by R1881 (Fig. 1A). Moreover, exposure to 
10-9-10-7 M of dihydrotestosterone (DHT) also increased ROS 
generation (data not shown). The results indicate that the 
DP6-AR cells generated ROS in response to androgen. We al-
so demonstrated that the androgen-induced ROS generation 
was suppressed by the ROS scavenger NAC (Fig. 1A). Laser 
scanning confocal microscopy revealed that exposure to 10-7 
M R1881 produced a significant increase in ROS in DP6-AR 
cells; the effect was similar to that of H2O2 and was inhibited 
by NAC (Fig. 1B). 
Androgen-inducible ROS augmented TGF-b1 secretion from 
DPCs 
ROS has been reported to induce TGF-β in epithelial cells (13) 
and TGF-β1 is known to inhibit the proliferation of hair epi-
thelial cells (11). To investigate the effects of oxidative stress, 
DP6-AR cells were treated with 10, 50, or 100 μM H2O2. The 
H2O2-treated DP6-AR cells showed 2-3-fold dose- dependent 
increases in the secretion of active TGF-β1 compared to the 
untreated cells (Fig. 2).
Androgen-induced TGF-β1 secretion was reversed by a ROS 
scavenger
Next, we measured the levels of active TGF-β1 in conditioned 
media after treating the cells with various concentrations of 
R1881 for 48 h. We found that the levels of active TGF-β1 
dose-dependently increased at R1881 concentrations of 
10-9-10-7 M (Fig. 3). To determine whether ROS scavengers 
have suppressive effects on androgen-induced TGF-β1 regu-
lation, we analyzed the effects of NAC on androgen-induced 
TGF-β1 secretion. Pre-treatment of DP6-AR cells with NAC at 
0.25-2.5 mM for 2 h reduced the active TGF-β1 secretion 
when R1881 was added at 10-7 M compared to the control that 
was treated with only 10-7 M R1881 (Fig. 3). This result dem-
onstrates that the ROS scavenger reversed the androgen-in-
duced TGF-β1 secretion by the DPCs. These observations in-
dicate that ROS is involved in the increased secretion of 
TGF-β1 from DPCs induced by androgen. 
NAC suppressed the androgen-induced TGF-β1 secretion by 
the DPCs 
We performed promoter assays using the luciferase reporter 
gene to investigate the suppression of TGF-β1 by a ROS scav-
ROS-mediated TGF-β1 regulation in DPCs
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Fig. 3. Androgen-inducible ROS augmented the TGF-β1 secretion 
by dermal papilla cells. Increased active TGF-β1 secretions were 
observed after treatment with various concentrations of R1881 for 
48 h (lane C, D, E, F). Comparatively, when the cells were ini-
tially pre-treated with NAC (0.25-2.5 mM) for 2 h, the active 
TGF-β1 secretions were reduced (lane G, H, I, J). Lane A repre-
sents the control cells transfected with the mock vector only. All 
results are the mean values of experiments performed in triplicate. 
Error bars indicate the standard errors. ANOVA was performed at 
first and independent t-test was done for post hoc. *P ＜ 0.05 
versus untreated DP6-AR cells (lane B). **P ＜ 0.05 versus the 
control which was treated with only R1881 (lane E). 
Fig. 4. Luciferase assays analyzing the TGF-β1 promoter levels af-
ter treatment with androgen and NAC. The DP6-AR cells were 
transiently transfected with the pGL3-TGF-β1-Luc reporter plasmid 
and the pRL-TK vector. First lane, pRL-TK vector only as a neg-
ative control; 2nd lane, 10-7 M R1881; 3rd lane, 10-7 M R1881 + 
2.5 mM NAC; 4th lane, 1 nM DHT; 5th lane, 1 nM DHT + 2.5 
mM NAC. At 48 h after treatment, the cells were harvested for 
the luciferase assays. The luciferase activities were measured using 
a luminometer. All results are the mean values of experiments 
performed in triplicate. Error bars indicate the standard errors. 
When the first, the second, and the third lane were compared, 
ANOVA was performed at first and independent t-test was done 
for post hoc. In comparison with the 2nd and the 3rd lane, or 
with the 4th and the 5th lane, independent t-test was done. *P ＜
0.05 versus a negative control. **P ＜ 0.05 versus the control 
that was treated with only R1881. ***P ＜ 0.05 versus the con-
trol that was treated with only DHT.
enger at the transcriptional level. DP6-AR cells co-cultured in 
the presence of 10-7 M R1881 or 10-9 M DHT stimulated the 
TGF-β1 promoter. Comparatively, luciferase reporter assays 
demonstrated that TGF-β1 promoter signaling was transcrip-
tionally suppressed after the addition of 2.5 mM NAC in the 
presence of R1881 or DHT (Fig. 4). This observation suggests 
that the secretion of androgen-induced TGF-β1 in the DP6-AR 
cells is suppressed at the transcriptional level by pre-treatment 
with NAC. These results clearly demonstrate that antioxidants 
are able to block androgen-inducible TGF-β1 secretion from 
DPCs. 
DISCUSSION 
Balding scalp DPCs secret inhibitory factors that affect hair 
growth (15). In particular, the inhibitory role of androgens in 
keratinocyte growth was confirmed by Inui et al. (11). In addi-
tion, it has been reported that androgen-inducible TGF-β1 from 
balding DPCs is an inhibitory paracrine mediator in AGA (11, 
16). Thus, it has been well established that the progression of 
AGA is associated with androgen and TGF-β1 levels. 
　Studies by Ripple et al. (14) showed that androgens are ca-
pable of enhancing oxidative stress in androgen responsive 
LNCaP prostate carcinoma cells. Thus, it appears that androgens 
may play a significant role in regulating the cellular redox 
state, particularly with respect to ROS homeostasis in epithelial 
cells. In addition, ROS has been reported to induce TGF-β in 
epithelial cells (13), and therefore, androgens are involved in 
ROS generation, and ROS is related to TGF-β secretion. 
Moreover, these factors are involved in AGA. Consequently, 
we examined whether androgens are capable of increasing 
ROS production in dermal papilla cell lines, and if so, whether 
such mediation plays a role in AGA development. 
　During sub-cultivation of DPCs, sensitivity to androgens 
may be low because of the reduced expression level of AR 
(11). AR has been detected in the DPCs of human skin (5), and 
the DPCs of bald frontal scalps express higher levels of AR 
than those of non-balding occipital scalps (4). Therefore, to con-
firm our hypothesis, we used rat DPCs that over-express AR. 
　The ELISA and promoter assay showed that ROS induced 
TGF-β1 secretion in the DPCs, and that NAC inhibits an-
drogen-induced TGF-β1 secretion at the transcriptional level 
(Fig. 2 and 4). Ascorbic acid, which is a well-known anti-
oxidant, has been shown to stimulate DP cell growth and pro-
mote hair shaft elongation in vitro and in vivo in animal ex-
periments (17). Moreover, green tea epigallocatechin-3-gallate, 
which is known to have potent antioxidant effects, was re-
ported to promote hair growth (18). These findings, in con-
junction with the present study illustrate the beneficial effects 
of antioxidants on hair growth, and offer a mechanistic basis 
for these effects. 
　In conclusion, the present study demonstrates that androgen- 
induced TGF-β1 regulation is mediated by ROS, and can be 
prevented by antioxidants in hair follicle DPCs. Moreover, our 
ROS-mediated TGF-β1 regulation in DPCs
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findings suggest the potential use of antioxidant therapy for the 
treatment of androgenetic alopecia. 
MATERIALS AND METHODS
ROS generation assay and confocal microscopy 
Intracellular H2O2 and hydroxyl radical levels were determined 
by measuring 2',7'-dichlorofluorescein diacetate (DCFDA; 
Molecular Probes, Eugene, OR) fluorescence. Non-fluorescent 
DCFDA is hydrolyzed to yield highly fluorescent dichloro-
fluorescein (DCF) in the presence of intracellular H2O2 and re-
lated peroxides. 
　After treatment with 10-9 and 10-7 M of the synthetic an-
drogen, methyltrienolone (R1881; Sigma, St. Louis, MO), for 
24 h, 1.0 × 106 DP6-AR cells were harvested, washed twice 
with PBS, resuspended in serum-free medium, and incubated 
with 10 μM DCF-DA in Hanks balanced salt solution (HBSS) at 
37oC for 30 min. They were then washed with ice-cold 4-(2- 
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)/saline 
and placed on ice. Cellular fluorescence was measured by 
flow cytometry using a FACS Calibur flow cytometer (BD 
Biosciences, Mississanga, ON, Canada). As a positive control, 
1.0 × 106 DP6-AR cells were treated with 100 μM H2O2 and 
then processed. 
　The cells were imaged using a Zeiss LSM 510 META con-
focal microscope (200×; Carl Zeiss MicroImaging, Inc, Thorn-
wood, NY). The green fluorescence of DCF was excited at 488 
nm using an argon laser and detected at 527 nm. Laser attenu-
ation, pinhole diameter, and photomultiplier sensitivity and 
offset were maintained for all experiments. For imaging, glass 
coverslips were mounted in a recording chamber filled with 
HBSS. 
TGF-β1 determination by ELISA 
The DP6-AR (5.0 × 105 cells/dish) were treated with 10, 50, or 
100 μM H2O2 for 24 h, and the conditioned media were 
harvested. After pre-incubation with N-acetyl cysteine (NAC) 
for 2 h, 1.0 × 105 DP6-AR cells/6-well plates were treated 
with R1881 (10-9, 10-8, 10-7, and 10-6 M) for 48 h, and the con-
ditioned media were harvested. The concentration of TGF-β1 
in the conditioned media was measured using ELISA, according 
to the manufacturer’s instructions (R&D Systems, Minneapolis, 
MN), as previously described (19). 
Others
Chemicals and reagents, as well as the protocols for the plas-
mid construction, cell culture, transfection, western blot, re-
porter gene assays, and statistical analyses are described in the 
supplementary materials and methods. 
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